Status:

UNKNOWN

Virtual Reality-based Rehabilitation

Lead Sponsor:

Universitat Pompeu Fabra

Conditions:

Patients With Unilateral Peripheral Vestibular Deficits

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Vertigo / dizziness, imbalance and other symptoms related to vestibular pathology have a life prevalence of 7.4%. Peripheral and unilateral vestibulopathy are among the most common types, and in some ...

Eligibility Criteria

Inclusion

  • Unilateral vestibular deficit
  • Vestibular neuritis
  • Sudden hearing loss with vestibular involvement
  • Labyrinthitis
  • Ménière's disease
  • Vestibular Shwannoma
  • Benign paroxysmal positional vertigo
  • Vestibular symptoms (vertigo, dizziness, imbalance, gait instability, kinosis and / or oscillopsy) chronic (more than 6 weeks of evolution)
  • Over 18 years old

Exclusion

  • Failure to meet some of the inclusion criteria
  • Neurological, traumatological, rheumatological, ophthalmological or systemic pathology that may interfere with the balance
  • Inability to understand participation in the study
  • Non-acceptance to participate in the study

Key Trial Info

Start Date :

January 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2021

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT04280302

Start Date

January 1 2020

End Date

March 1 2021

Last Update

February 21 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital Universitari de Tarragona Joan XXIII

Tarragona, Spain, 43005